Bavarian Nordic, SGS Partner for Respiratory Vaccine
By

By
Bavarian Nordic, a Kvistgaard, Denmark-based biotechnology company, has partnered with SGS, a contract analytical laboratory, to develop a new respiratory syncytial virus (RSV) challenge strain. SGS says the partnership will…

Merck & Co., Aeglea BioTherapeutics Partner in Immuno-Oncology
By

By
Merck & Co. and Aeglea BioTherapeutics, an Austin, Texas-headquartered biotechnology company, have entered into a clinical collaboration to evaluate the combination of Merck & Co.’s anti-PD-1 therapy, Keytruda (pembrolizumab), with…

Roche Partners in Drug-Resistant Antibiotics
By

By
Roche and Warp Drive Bio, a Cambridge, Massachusetts-headquartered pharmaceutical company, have partnered to develop antibiotics for drug-resistant bacterial infections in a deal worth up to $300 million. Under the collaboration,…

FDA OKs Second Samsung BioLogics’ Biomanufacturing Facility in Korea
By

By
The US Food and Drug Administration (FDA) has licensed Samsung BioLogics’ biomanufacturing facility in Incheon, South Korea for monoclonal antibody drug substance production. Samsung BioLogics is a contract biologics manufacturer.…

Lupin Completes $150-Million Acquisition of Symbiomix Therapeutics
By

By
Lupin, a Mumbai, India-headquartered pharmaceutical company, has completed its $150-million acquisition of Symbiomix Therapeutics, a Newark, New Jersey-headquartered biotechnology company. Lupin agreed to acquire the company earlier in 2017. The…

Xellia To Invest $25 Million to Expand Sterile Drug Product Manufacturing
By

By
Xellia Pharmaceuticals, a Copenhagen, Denmark-headquartered specialty pharmaceutical company focused on anti-infective treatments, has broken ground on a new $25-million facility for sterile manufacturing at its Copenhagen site, which is the…

CordenPharma To Acquire Pfizer API Manufacturing Facility
By

By
CordenPharma, a contract development and manufacturing organization of drug substances and drug products, has agreed to acquire a manufacturing facility located in Boulder, Colorado from Hospira, a Pfizer company. The…

Friulchem Advances Rifaximin Manufacturing
By

By
Friulchem S.p.A., a Vivaro, Italy-based contract development and manufacturing organization for innovator and generic pharmaceutical products for human and veterinary use, reports on manufacturing developments for rifaximin, an active pharmaceutical…

Pfizer Considers Sale of Consumer Healthcare Business
By

By
Pfizer is reviewing strategic alternatives for its consumer healthcare business, including a full or partial separation of the business from Pfizer through a spin-off, sale, or other transaction. Pfizer’s consumer…

Calif. Governor Signs Drug-Price Transparency Bill
By

By
California Governor Edmund G. Brown Jr. has signed legislation, Senate Bill (SB) 17, Healthcare: Prescription Drug Costs, to increase transparency in prescription drug pricing by requiring pharmaceutical companies to give…